NEW YORK (360Dx) — Theranos said late Monday that it reached a deal with the Centers for Medicare & Medicaid Services to settle all outstanding legal and regulatory proceedings against the firm.

Separately, the firm today said it will reimburse Arizona residents $4.65 million for blood testing services that it performed between 2013 and 2016. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.